Oruka Therapeutics has reported positive interim data from the ongoing EVERLAST-A Phase IIa trial evaluating ORKA-001 in patients with moderate-to-severe plaque psoriasis.
The post Oruka reports positive data from Phase IIa trial for plaque psoriasis appeared first on Clinical Trials Arena.
HHS is urging the public to report hospitals and nursing homes that serve sugary drinks, nutrition shakes or meals that don’t meet new dietary guidelines, and …
قال الدكتور محمد عبد المعطى سمره، عميد المعهد القومى للأورام، إنه لا يوجد طعام واحد محدد قادر على الوقاية من السرطان، كما إنه لا يوجد طعام …
Currently, hospital pharmacy teams need to carefully prepare the drug in intravenous bags under sterile conditions, which can be time-consuming for NHS staff